Literature DB >> 7894001

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.

A B Chapman1, A M Johnson, P A Gabow, R W Schrier.   

Abstract

The amount of proteinuria is a prognostic indicator in a variety of glomerular disorders. To examine the importance of urinary protein excretion in autosomal dominant polycystic kidney disease, this study determined the clinical characteristics of autosomal dominant polycystic kidney disease patients with established proteinuria and the frequency of microalbuminuria in hypertensive autosomal dominant polycystic kidney disease patients without proteinuria. In 270 autosomal dominant polycystic kidney disease patients, mean 24-h urinary protein excretion was 259 +/- 22 mg/day. Forty-eight of 270 autosomal dominant poly-cystic kidney disease patients had over proteinuria (> 300 mg/day). The patients with established proteinuria had higher mean arterial pressures, larger renal volumes, and lower creatinine clearances than did their nonproteinuric counterparts (all P < 0.0001), a greater pack year smoking history (P < 0.05), and the projection of a more aggressive course of renal disease (P < 0.05). All autosomal dominant polycystic kidney disease patients with established proteinuria were hypertensive, as compared with 67% without established proteinuria (P < 0.001). Forty-nine patients with hypertension and left ventricular hypertrophy without established proteinuria were examined for microalbuminuria; 41% demonstrated microalbuminuria. Those with microalbuminuria had higher mean arterial pressure, larger renal volumes and increased filtration fraction. Therefore, established proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease patients are associated with increased mean arterial pressure and more severe renal cystic involvement.

Entities:  

Mesh:

Year:  1994        PMID: 7894001     DOI: 10.1681/ASN.V561349

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  65 in total

1.  Environmental tobacco smoke furthers progression of diabetic nephropathy.

Authors:  David M Obert; Ping Hua; Meagan E Pilkerton; Wenguang Feng; Edgar A Jaimes
Journal:  Am J Med Sci       Date:  2011-02       Impact factor: 2.378

2.  Geographic differences in the increasing ESRD rate have disappeared in Japan.

Authors:  Tamaki Wakamatsu-Yamanaka; Michio Fukuda; Ryo Sato; Takehiro Naito; Hiroyuki Togawa; Tatsuya Tomonari; Yoko Kato; Toshiyuki Miura; Masashi Mizuno; Tadashi Ichikawa; Sota Miyagi; Yuichi Shirasawa; Akinori Ito; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2011-06-03       Impact factor: 2.801

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Authors:  Piero Ruggenenti; Giorgio Gentile; Norberto Perico; Annalisa Perna; Luca Barcella; Matias Trillini; Monica Cortinovis; Claudia Patricia Ferrer Siles; Jorge Arturo Reyes Loaeza; Maria Carolina Aparicio; Giorgio Fasolini; Flavio Gaspari; Davide Martinetti; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Anna Caroli; Kanishka Sharma; Luca Antiga; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-22       Impact factor: 8.237

Review 5.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

6.  Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Michel Chonchol; Berenice Gitomer; Tamara Isakova; Xuan Cai; Isidro Salusky; Renata Pereira; Kaleab Abebe; Vicente Torres; Theodor I Steinman; Jared J Grantham; Arlene B Chapman; Robert W Schrier; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-13       Impact factor: 8.237

Review 7.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

8.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

9.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

10.  Autosomal dominant polycystic kidney disease with diffuse proliferative glomerulonephritis - an unusual association: a case report and review of the literature.

Authors:  Sanjay D'Cruz; Rajdeep Singh; Harsh Mohan; Ravinder Kaur; Ranjana Walker Minz; Vinay Kapoor; Atul Sachdev
Journal:  J Med Case Rep       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.